Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US COVID-19 Relief Law Boosts Pharmaceutical Manufacturing Programs; Is More To Come?

Executive Summary

$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.

You may also be interested in...



US Bills Aim To Reduce Pharma Manufacturing Reliance On China

A US bipartisan Senate bill and House proposal aim to bring pharma manufacturing from China to closer to home, through partnerships with American universities to train the workforce and develop technologies.

Time Is Now To Seek US Funding, Financing To Expand Domestic COVID-19 Vaccine Supply Chain

BARDA and Development Financing Corp. officials provide insights into window of opportunity for partnering on manufacturing scale-up.

Public-Private Consortium To Strengthen Essential Medicines Supply Under White House Initiative

President Biden’s 100-day plan relies on Defense Production Act authorities to increase resilience of critical domestic pharmaceutical supplies.

Related Content

Topics

UsernamePublicRestriction

Register

PS143973

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel